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136Transglutaminase type 2 in human abdominal
aortic aneurysm is a potential factor in the
stabilization of extracellular matrix
Sung Shin, MD,a Yong-Pil Cho, MD, PhD,a Heungman Jun, MD,a Hojong Park, MD,a
Hea Nam Hong, PhD,b and Tae-Won Kwon, MD, PhD,a Seoul, Korea
Objective: The aim of this study was to evaluate transglutaminase type 2 (TG2) expression in human abdominal aortic
aneurysm (AAA) tissue and to elucidate a potential role of TG2 in AAA formation. TG2, which is a Ca2D-dependent
cross-linking enzyme, has been proven important for stabilizing the extracellular matrix. However, there is no evidence of
the effect of TG2 on AAA formation in a human model.
Methods: Aortic wall tissues were obtained during surgery in AAA patients (n [ 38) and in patients with aortoiliac
occlusive disease (Control; n[ 4) in the Asan Medical Center from March 2011 to February 2012. In each AAA patient,
the aortic neck (Neck) and maximally dilated portion (Max) of the aneurysm were sampled for analysis. TG2 expression
was evaluated using immunohistochemistry and Western blotting. In addition, ex vivo experiments of isolated AAA tissue
culture with the TG2 inhibitor cystamine and recombinant human TG2 were performed.
Results: Among 38 AAA patients, 11 had ruptured (contained or free) AAAs. The mean maximal diameter of AAAs was
6.09 ± 1.46 cm. TG2 expressions of Max were signiﬁcantly increased compared with those of Control (1.7-fold increase
of Control; P [ .00). Compared with Control, the intensities of tissue necrosis factor-a, matrix metalloproteinase
(MMP)-2, MMP-9, and tissue inhibitors of metalloproteinase-2 were signiﬁcantly upregulated in Max (1.7-fold,
1.5-fold, 1.3-fold, and 1.6-fold increases of Control; P [ .00, P [ .004, P [ .046, and P [ .007, respectively).
Furthermore, double immunoﬂuorescent staining showed that colocalization of TG2/transforming growth factor-b or
TG2/ﬁbronectin was prominent in Max compared with those of Neck or Control. In addition, MMP-2 intensity was
upregulated in ruptured AAAs compared with unruptured AAAs, with marginal signiﬁcance (P [ .078). Ex vivo
experiments showed that protein expressions of tissue necrosis factor-a, MMP-2, and MMP-9 in cultured AAA tissue
were decreased by recombinant human TG2 but were increased by exogenous cystamine.
Conclusions: The TG2 expression in themaximally dilated portion of AAAswas enhanced comparedwith that of nondilated
aorta. It is suggested that TG2has a potential effect in stabilization of extracellularmatrix by inhibition of proinﬂammatory
cytokines andMMPsor by interactionwith ﬁbronectin and transforming growth factor-b. (J Vasc Surg 2013;57:1362-70.)
Clinical Relevance: Transglutaminase type 2 (TG2), which is a Ca2D-dependent cross-linking enzyme, has been known be
to important in stabilizing the extracellular matrix. In a rat abdominal aortic aneurysm (AAA) model, TG2 has a
protective effect on AAA formation, whereas there has been no evidence of the effect of TG2 on AAA formation in a
human model. This is the ﬁrst study to suggest that TG2 has a potential effect in the stabilization of extracellular matrix
in a human model. It is expected that our results may serve as the foundation to develop a preventive remedy for AAA.Abdominal aortic aneurysms (AAAs) are a common
degenerative disease with life-threatening consequences.
Development of AAAs proceeds by a multifactorial process
that includes inﬂammation and extracellular matrix degra-
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2collagens, laminin, heparan sulfate, and other glycopro-
teins, provides a structural framework and interaction
essential for the aortic walls.2 Matrix metalloproteinases
(MMPs), which degrade extracellular structural proteins
such as elastin and collagen and regulate tissue remodeling
in a variety of pathophysiologic conditions, could be impli-
cated in the formation of AAAs.3-6 Their activities are regu-
lated by endogenous metalloproteinase inhibitors, called
tissue inhibitors of metalloproteinases (TIMPs).2,3 The
balance between MMP and TIMP expression is considered
to regulate the net degeneration of extracellular matrix.2,3,7
Transglutaminase type 2 (TG2) is another regulator in
the extracellular matrix organization.2 It is a member of the
transglutaminase enzyme family, involved in a plethora of
biologic functions such as angiogenesis,8 apoptosis,9 cell
differentiation,10 and wound healing.11,12 It has been re-
ported that extracellular TG2 has a role in cell adhesion,
whereas intracellular TG2 is involved in regulation of endo-
thelial cell proliferation and apoptosis.13
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AAA formation. Recently, it was suggested that TG2 has
a potential role as an extracellular matrix protector in
AAA formation, which is suggested in a rat AAA model
using a combination of intraluminal elastase infusion and
extraluminal calcium chloride.2,14 Munezane et al2 report-
ed that TG2 mRNA expression in the AAAs was signiﬁ-
cantly upregulated. In addition, ex vivo experiments
showed that mRNA expression of tissue necrosis factor
(TNF)-a, MMP-2, and MMP-9 in the cultured AAA tissue
was decreased by exogenous TG2 but was increased by
cystamine. However, this theory is not yet established in
human AAAs.
We hypothesized that TG2 expression in a maximally
dilated portion was increased compared with that in a non-
dilated portion of human AAA and that exogenous TG2
might decrease the expression of MMPs and inﬂammatory
cytokines, whereas cystamine might increase their expres-
sion in human AAA-derived smooth muscle cell (HA-
SMC) cultures. Based on our hypotheses, aortic tissues
from aortic necks and maximally dilated portions in
patients with AAAs were sampled during the surgery and
analyzed. Furthermore, ex vivo experiments were per-
formed to verify the effects of TG2 or cystamine on
MMPs and inﬂammatory cytokines.
The aim of this study was to evaluate aortic TG2
expression in human AAA tissue and to elucidate a potential
role of TG2 in AAA formation.
METHODS
Preoperative evaluation of AAAs. Preoperative
computerized tomographic angiography was performed
to evaluate characteristics of AAAs in all patients. Diame-
ters of Neck and Max were measured and characteristics
of AAAs were determined morphologically (fusiform or
saccular), anatomically (infrarenal or juxtarenal), and
clinically (intact or ruptured) according to computerized
tomographic angiography. The dilation ratio was calculated
according to the formula suggested by Munezane et al2:
Dilation ratio (%) ¼ ([Max diameter – Neck diameter]/
Neck diameter)  100.
Sampling of aortic tissues. The study was approved
by the Institutional Review Board of the Asan Medical
Center, and participation of all enrolled patients was based
on informed consent of patients. Aortic wall tissues were
obtained during surgery for either AAA (n ¼ 38) or aor-
toiliac occlusive disease (Control; n ¼ 4) in the Asan
Medical Center from March 2011 to February 2012. After
atherosclerotic plaque or intraluminal thrombus was
removed, aortic wall tissues were sampled in full thickness,
and the size of each obtained tissue was usually 1.5 to 2 cm
in diameter. In each AAA patient, aortic neck (Neck) and
maximally dilated portion (Max) of the aneurysm were
sampled for analysis. For control, aortic tissues were
extracted from infrarenal aorta adjacent to proximal anasto-
mosis before aortic reconstruction in patients with aortoil-
iac occlusive disease. In patients with ruptured AAAs
(n ¼ 11), aortic tissue around the ruptured area wassampled as well as Max. One portion of each specimen
was snap-frozen in liquid nitrogen, stored at 20C, and
subsequently used for Western blot analysis. An adjacent
portion was ﬁxed in 4% paraformaldehyde and processed
for routine embedding in parafﬁn.
Western blot analysis. Total protein was extracted
from aortic tissues or cultured smooth muscle cells by lysis
in protein extraction solution (Pro-Prep; iNtRON Biotech-
nology, Seongnam, Korea). Extracted proteins (20 mg) were
electrophoresed on 10% sodium dodecyl sulfate polyacryl-
amide gel electrophoresis acrylamide gels for 70 minutes at
130 V and transferred onto nitrocellulose membranes
(Bio-Rad, Richmond, Calif). Membranes were blocked for
1 hour in blocking buffer (2% bovine serum albumin in
Tween20/Tris-buffered saline). Then, primary antibody
was added and incubated overnight at 4C. The following
primary antibodies were used: polyclonal anti–TG-2 (1:500;
GTX22972; Genetex, Irvine, Calif), monoclonal anti–
MMP-2 (1:200; SC13595; Santa Cruz, Dallas, Tex), poly-
clonal anti–MMP-9 (1:1000; #2270S; Cell Signaling,
Danvers, Mass), polyclonal anti-TIMP1 (1:1000; AB770;
Chemicon, Temecula, Calif), monoclonal anti–TIMP-2
(1:1000; MAB3310; Chemicon), and monoclonal anti–
TNF-a (1:500; ab1793; Abcam, Cambridge, Mass), then
horseradish peroxidase anti-mouse (1:2000; Invitrogen,
Seoul, Korea) or anti-rabbit (1:5000; Invitrogen) for 1 hour
at room temperature, followed six times by Tris-buffered
saline washes. Immunoreactive bands were visualized by
electrogenerated chemiluminescent reagents (Millipore,
Billerica, Mass). The optical density of bands was analyzed
by reﬂectance densitometry on a Bio-Rad GS-670 imaging
densitometer. The density of each enzyme was divided by
that of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). Anti-GAPDH antibody (1:1000; ab9485;
Abcam) was used as the antibody source for GAPDH.
Immunohistochemistry. Indirect immunoﬂuores-
cence was performed on 4-mm-thick tissue sections after
permeabilization with 0.3% Triton X-100. Sections were
incubated overnight at 4C with primary antibodies at
recommended dilutions in blocking solution. Primary
antibodies used were polyclonal anti-TG-2 (1:500;
GTX22972; Genetex), polyclonal anti-elastin (1:200;
ab21610; Abcam), monoclonal anti-transforming growth
factor (TGF)-b (1:500; MAB1032; Millipore), and
monoclonal anti-ﬁbronectin (1:100; ab6328; Abcam).
Sections were incubated with Alexa-488 or Alexa-555
conjugated anti-rabbit (1:500) or anti-mouse (1:200;
Invitrogen) secondary antibodies, as appropriate, for
2 hours at room temperature. As a negative control, one
section was processed without applying primary antibodies.
All slides were mounted using Fluoromount (South-
ernBiotech, Birmingham, Ala) and then examined under
a ﬂuorescence microscope (Leica, Wetzlar, Germany).
Cultures of HA-SMC. The HA-SMC cultures were
established by the explant technique, as described elsewhere
but with some modiﬁcations.15 In brief, isolated aortic
tissues (n ¼ 2) from ruptured AAA patients were dissected
immediately after harvest to remove the intimal and
Table. Baseline characteristics of patients (n ¼ 38)
undergoing repair of AAAs
Variables No. Percentage
Male gender 34 89
Age, mean (SD) 66.68 (8.33)
BMI, mean (SD), kg/m2 23.98 (3.03)
Dyslipidemiaa 20 52
Diabetes mellitus 9 23
Smoking
No smoking in recent 10 years 12 31
Past 6 15
Current 20 52
Hypertension 27 71
Cerebrovascular accident 6 15
Coronary artery diseaseb 13 34
Renal dysfunctionc 7 18
Pulmonary dysfunction 11 28
Carotid stenosisd 2 5
Etiologic classiﬁcation 3
Degenerative 4 89
Inﬂammatory 4 10
Morphologic classiﬁcation
Fusiform 37 97
Saccular 1 2
Anatomic classiﬁcation
Infrarenal 27 71
Juxtarenal 11 28
Clinical classiﬁcation
Asymptomatic 21 55
Intact, but symptomatic 6 15
Rupture (free or contained) 11 29
Multiplicity 28 73
Diameter of AAA, mean (SD), cm 6.09 (1.47)
Dilation ratio,e % (SD) 150.36 (67.44)
AAA, Abdominal aortic aneurysm; BMI, body mass index; SD, standard
deviation.
Values are given as number and percentage unless otherwise indicated.
aLow-density-lipoprotein cholesterol 100 mg/dL.
bHistory of previous myocardial infarction, percutaneous coronary
intervention, coronary artery bypass graft, and/or presence of ischemic
changes on electrocardiogram.
cSerum creatinine level >1.5 mg/dL.
dCarotid stenosis >50%.
e([Maximal diameter – Neck diameter]/Neck diameter)  100.
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0-5 mm square pieces and incubated in DMEM-F12
medium (Invitrogen) containing 100 U of collagenase
type II (325 U/mg; Sigma, St. Louis, Mo) and 30 U of
elastase (135 U/mg; Elastin Products, Owensville, Mo) for
60 minutes at 37C. The enzymatically digested tissue
pieces were collected by centrifugation and incubated in six-
well dishes with DMEM-F12 containing 15% fetal bovine
serum. Over 2 weeks, primary SMCs migrated out of the
tissue fragments onto the surface of the dish. When these
primary cells reached 70% to 90% conﬂuence, they were
passaged into fresh dishes containing DMEM-F12 supple-
mented with 10% fetal bovine serum, 20 ng/mL basic
ﬁbroblast growth factor, and 20 ng/mL epidermal growth
factor. The HA-SMCs at early passage (passages 3-6) were
used in all experiments. The HA-SMCs were grown for 7
days in different concentrations of recombinant human TG2
(1, 5, and 10 mg/mL; R&D Systems, Minneapolis, Minn)
and the TG2 inhibitor cystamine (5, 10, and 20 mg/mL;
Sigma-Aldrich, St. Louis, Mo) to investigate the effects of
TG2 on MMPs and inﬂammatory cytokines. The strong
immunostaining for a-smooth muscle actin (1:500; Sigma-
Aldrich) conﬁrmed the SMC phenotype of isolated and
cultured cells with a purity >95%.
Statistical analysis. All values are expressed as
mean 6 SEM. Comparisons between Control and Max
were performed with an unpaired Student t-test; compari-
sons between Max and Neck were made with a paired
t-test. P < .05 was considered statistically signiﬁcant. All
statistical analyses were performed using SPSS software
(SPSS, Inc, Chicago, Ill).
RESULTS
Characteristics of patients and AAAs. During the
study period, 38 consecutive patients underwent open
repairs of AAAs and four patients with aortoiliac occlusive
disease underwent bypass operations. Characteristics of
patients with AAAs are given in the Table. The median age
was 66.68 years (range, 51-93 years), and 34 patients (89%)
were men. Mean aneurysm diameter was 6.09 cm (range,
3.9-10.0 cm). The main cardiovascular risk factors were
hypertension in 27 patients (71%), dyslipidemia in 20 (52%),
tobacco use in 26 (68%), and diabetes in nine (23%).
Among the AAAs, 34 (89%) were degenerative in
etiology; most were fusiform in shape except for one case
of saccular aneurysm. Anatomically, 27 AAAs (71%) were
infrarenal and the others were juxtarenal. Ruptured (free
or contained) AAA was diagnosed in 11 cases (29%). The
mean dilation ratio was 150.36% (range, 29.8%-368.1%).
Differential analysis between Max and Neck. Rela-
tive TG2 intensity was signiﬁcantly increased in Max
compared with Neck (P ¼ .03; Fig 1, B). Subgroup anal-
ysis revealed that TG2 intensity was signiﬁcantly increased
in Max compared with Neck in the infrarenal group
(P ¼ .006), whereas there was no signiﬁcant difference of
TG2 intensity between Max and Neck in the juxtarenal
group (3.5-fold and 3.8-fold increases of Control;
P ¼ .333). It is suspected that no difference was found inthe juxtarenal group because we could not sample normal
aortic neck in these patients. In the infrarenal group, the
intensities of MMP-2 (P ¼ .029) and MMP-9 (P ¼ .008)
were signiﬁcantly increased in Max compared with Neck.
Differential analysis between Control and Max.
Compared with Control, the intensities of TNF-a,
MMP-2, and MMP-9 were signiﬁcantly upregulated in
Max (Fig 1, A). Both TG2 and TIMP-2 intensities were
also signiﬁcantly upregulated in Max compared with
Control, whereas TIMP-1 did not show such a difference
(Fig 1, B). Immunoﬂuorescent staining showed that the
immunoreactivity of elastin is markedly decreased in Max
compared with Control (Fig 2, A). To investigate the
colocalization of TG2 and TGF-b in AAAs, double
immunoﬂuorescent staining for TG2 and TGF-b was per-
formed. The immunoreactivity of both TG2 and TGF-
b was diffusely enhanced throughout the aortic wall in Max
compared with that in Control or Neck (Fig 2, B). Double
Fig 1. Relative intensities and typical examples of Western blotting of tumor necrosis factor (TNF)-a, matrix metal-
loproteinase (MMP)-2, MMP-9 (A), transglutaminase type 2 (TG2), tissue inhibitors of metalloproteinase (TIMP)-1,
and TIMP-2 (B) in Max and Neck compared with Control. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase;
Max, maximally dilated portion of abdominal aortic aneurysm (AAA); NS, not signiﬁcant.**P < .01; *P < .05 vs
Control. n ¼ 3 for all.
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similar results (Fig 2, C).
Comparison between ruptured AAAs and unrup-
tured AAAs. The immunoreactivity of elastin in the
ruptured portion of AAAs was more decreased than in
Max (Fig 2, A). Because it is well known that TG2 inter-
acts with TGF-b or ﬁbronectin for extracellular matrix
stabilization, double immunoﬂuorescent staining for TG2/
TGF-b and TG2/ﬁbronectin was performed. Colocaliza-
tion of TG2/TGF-b and TG2/ﬁbronectin was more
apparent in ruptured portion of AAAs than in Max or
Neck (Fig 2, B and C).
Differences between ruptured (contained or free)
AAAs and unruptured AAAs were evaluated. Maximal
diameter of ruptured AAAs (7.3 6 0.5 cm) was signiﬁ-
cantly increased compared with unruptured AAAs (5.6 6
0.5 cm; P < .01). In addition, MMP-2 intensity was upre-
gulated in ruptured AAAs compared with unruptured
AAAs, with marginal signiﬁcance (P ¼ .078). The intensity
ratios of MMP-2 to TG2 and MMP-9 to TG2 were higher
in ruptured AAAs than in unruptured AAAs (0.94 6 0.14
vs 0.66 6 0.08 and 1.19 6 0.26 vs 0.87 6 0.17, respec-
tively); however, they did not reach statistical signiﬁcance.
Ex vivo experiment. To further evaluate the effect on
AAA formation, HA-SMC cultures were incubated withrecombinant human TG2 and the TG2 inhibitor cyst-
amine. At ﬁrst, the HA-SMC cultures were established by
the explant technique (Fig 3). After 7-day incubation with
cystamine, the intensity of TNF-a was signiﬁcantly
increased compared with AAA tissue without cystamine
(Control; Fig 4, A). The intensities of MMP-2 and MMP-
9 were also increased after incubation with cystamine
(Fig 4, B and C). However, the intensities of TNF-a,
MMP-2, and MMP-9 were decreased after incubation with
recombinant human TG2 (Fig 5).
DISCUSSION
This study revealed that TG2 expression in a human
AAA was increased compared with that in nondilated aorta.
In addition, through HA-SMC culture specimens, it is sug-
gested that TG2 potentially has an inhibitory effect on
TNF-a, MMP-2, and MMP-9, which are known to
contribute to produce aortic aneurysms.
To date, not a few studies reported in the literature
have evaluated the effect of MMPs or TIMPs on human
AAAs. It has been reported that the messenger ribonuclear
acid (mRNA) and protein levels of MMP-1, MMP-2,
MMP-3, MMP-9, and MMP-12 are signiﬁcantly increased
in harvested human aneurysms.16-21 The TIMPs known to
date bind to and inactivate most of the MMPs.22
Fig 2. Immunoﬂuorescent staining for elastin, transglutaminase type 2 (TG2), transforming growth factor (TGF)-b, and
ﬁbronectin. A, Immunoﬂuorescent staining for elastin (green). B, Double immunoﬂuorescent staining for TG2 (green)
and TGF-b (red).C, Double immunoﬂuorescent staining for TG2 (green) and ﬁbronectin (red). Sites of colocalization of
TG2/ TGF-b or TG2/ﬁbronectin are indicated as a yellow emission. Bar ¼ 100 mm. CTL, Control; Max, maximally
dilated portion of abdominal aortic aneurysm (AAA);Neck, aortic neck of AAA; Rupture, ruptured portion of AAA.
Fig 3. Human abdominal aortic aneurysm (AAA)-derived smooth muscle cell (HA-SMC) cultures. A, Primary cultures
of HA-SMCs were established by growth from explant of human aorta of AAA patients. B, Primary HA-SMCs were
derived by outgrowth from the aortic tissue explant over 2 weeks after explant culture. C, The HA-SMCs at passage
3 were immunostained with a-smooth muscle actin antibody. Bar ¼ 50 mm.
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of MMPs to TIMPs were higher in AAAs than in nondi-
lated regions, suggesting that compensatory expression ofTIMPs is insufﬁcient to counteract the degenerative
role of MMPs in the formation of AAAs. Longo et al23
demonstrated that macrophage-derived MMP-9 and
Fig 4. Relative intensities of tumor necrosis factor (TNF)-a (A), matrix metalloproteinase (MMP)-2 (B), and MMP-9
(C) after 7-day incubation of human abdominal aortic aneurysm (AAA)-derived smooth muscle cells (HA-SMCs) with
exogenous transglutaminase type 2 (TG2) inhibitor or without TG2 inhibitor (Control). GAPDH, Glyceraldehyde-3-
phosphate dehydrogenase. **P < .01 vs Control. n ¼ 3 for all.
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produce aneurysms in a murine model.
Munezane et al2 performed a study investigating the
effects of TG2 on AAA formation in a rat AAA model.
They revealed that TG2 expression and activity in AAA
formation were enhanced. It was suggested that TG2 has
a potential role as an extracellular matrix protector in
AAA formation. As pointed out in their study, however,
the rat AAA model lacks several features of the human
lesions, such as atherosclerosis and intraluminal throm-
bosis. To our knowledge, ours is the ﬁrst study to evaluate
the effect of TG2 on AAA formation in humans.
We showed that the intensity of TG2 was signiﬁcantly
increased in Max compared with that in Neck. This result
was conﬁrmed in the infrarenal subgroup, whereas nosigniﬁcant difference of TG2 intensity was found between
Max and Neck in the juxtarenal group. In addition, both
MMP-2 and MMP-9 were demonstrated to be upregu-
lated simultaneously in Max.
Of note, the intensities of TNF-a, MMP-2, andMMP-9
were upregulated with properties similar to those of TG2 in
AAAs when comparing Control and Max. In addition, the
immunoreactivity of elastin was markedly decreased in the
maximally dilated portion of AAAs (Fig 2, A). This ﬁnding
supports the fact that the destruction and degradation of
elastin ﬁbers caused by an increase in MMPs plays a pivotal
role in the development of AAAs and that the inﬂamma-
tion also contributes to the progression of AAAs.1,23,24
It is well demonstrated that TG2 interacts with TGF-b
or ﬁbronectin for extracellular matrix stabilization. The
Fig 5. Relative intensities of tumor necrosis factor (TNF)-a (A), matrix metalloproteinase (MMP)-2 (B), and MMP-9
(C) after 7-day incubation of human abdominal aortic aneurysm (AAA)-derived smooth muscle cells (HA-SMCs) with
recombinant human transglutaminase type 2 (rhTG2) or without rhTG2 (Control). GAPDH, Glyceraldehyde-
3-phosphate dehydrogenase; NS, not signiﬁcant. ** P < .01; *P < .05 vs Control. n ¼ 3 for all.
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forming a ﬁbronectin-TG2 matrix that supports cell adhe-
sion more effectively than ﬁbronectin alone.25-28 In addi-
tion, both ﬁbronectin and TG2 can interact with heparan
sulfate residues of the cell surface proteoglycans and
through this, support Arg-Gly-Asp (RGD)-independent
cell adhesion.27,28 Telci et al demonstrated that TG2
induction stimulates nuclear factor-kB activity, which is
paralleled by an increase in the expression and bio-
activation of TGF-b1, with a subsequent elevation in the
synthesis and deposition of collagens I, III, and IV and
ﬁbronectin into the extracellular matrix.29 These results
can be supported by double immunoﬂuorescent stainingfor TG2/TGF-b or TG2/ﬁbronectin in our study
(Fig 2, B and C). The colocalization of TG2/TGF-b or
TG2/ﬁbronectin was apparent in ruptured or maximally
dilated portion of AAAs, suggesting that TG2 may have
a stabilizing effect on AAAs by an interaction with
TGF-b or ﬁbronectin.
The intensity of TIMP-2 was increased with similar
properties to that of TG2, whereas no signiﬁcant difference
of TIMP-1 was found between Control and Max. Knox
et al19 suggested that large increases in MMP immunoreac-
tivity in diseased aortas overwhelm the more modest
increases in TIMP. Higashikata et al reached a similar
conclusion in their study in which compensatory expression
JOURNAL OF VASCULAR SURGERY
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role of MMPs in the formation of AAAs.3
It is estimated that 80% of the mortality from AAAs is
secondary to rupture, and the mortality rate from ruptured
AAAs approaches 90%.30 The aim of treatment should be
preventing such a catastrophe when a preventive remedy
for AAAs is being considered. We performed a subgroup
analysis between ruptured and unruptured AAAs to recog-
nize the differences of the intensities of related enzymes or
clinical variables. The maximal diameter of ruptured AAAs
was signiﬁcantly increased compared with unruptured
AAAs. It is consistent with the fact that the single best
method for predicting ruptured AAAs traditionally has
been AAA diameter.31 The intensity ratios of MMP-2 to
TG2 and MMP-9 to TG2 were not higher signiﬁcantly
in ruptured AAAs than in unruptured AAAs. With the
limited cases of ruptured AAAs, it was not effective to
distinguish the differences of enzymatic expressions
between the two groups.
The HA-SMCs at early passage (passages 3-6) were
used in our experiments as performed with HA-SMC
cultures by Walton et al.32 It was revealed that the intensi-
ties of TNF-a, MMP-2, and MMP-9 in cultured AAA
tissues were increased by the TG2 inhibitor cystamine but
were decreased by recombinant human TG2. This ﬁnding
suggests that TG2 potentially has inhibitory effects not
only on TNF-a but also on MMP-2 and MMP-9. Similar
to experiments in a rat model by Munezane et al,2 no statis-
tically signiﬁcant differences in TIMP-1 and TIMP-2 were
found. Ahn et al33 previously demonstrated that TG2
inhibits MMP-9 via downregulation of MMP-9 transcrip-
tion activity by blocking the binding of the Jun-fos complex
to an AP-1 site, which supports our results. With regard to
TNF-a, MMP-2, and MMP-9 as potential biomarkers for
AAA development,23,34 our results support that TG2 can
contribute to stabilization of the aortic wall by inhibiting
elastolytic enzymes or proinﬂammatory cytokines, resulting
in prevention of AAA aggravation or rupture.
There are some limitations to our study. First, athero-
sclerotic aorta was used as control to compare with AAA
tissue. Because TG2 is implicated in ﬁbrosis and vascular
calciﬁcation contributing to arterial stiffness,35 atheroscle-
rotic aorta is not considered an ideal control. Instead, aorta
of cadaveric donor should be considered as control in
further research on TG2. Nevertheless, our study provided
obvious results showing signiﬁcant differences in enzymatic
expressions, including TG2 between AAA and Control.
Second, it was insufﬁcient to evaluate the differences of
TG2 and MMPs intensity between ruptured and unrup-
tured AAAs because of the low number of ruptured AAA
patients, which might lead to a potential bias of simple
aneurysm size to the results. It would be necessary to
perform additional analyses of TG2, MMPs, and cytokines
to evaluate contributory or inhibitory factors to AAA
rupture. Third, we failed to establish a relationship between
TG2 and TIMPs in ex vivo experiments. The TIMPs
known to date bind to and inactivate most of the
MMPs.22 Our study suggested that TG2 potentially hasan inhibitory effect on MMP-2 and MMP-9. Because
both TG2 and TIMP-2 intensities were signiﬁcantly upre-
gulated in the maximally dilated portion of AAAs
compared with Control in our study, further research is
needed to elucidate the interaction between them with
regard to AAA formation.
CONCLUSIONS
The present study is the ﬁrst to evaluate the potential
role of TG2 in a human AAA model. It is suggested that
TG2 is a potential factor in stabilization of the aortic wall
against AAA progression by the inhibition of proinﬂamma-
tory cytokines and MMPs or by interaction with ﬁbronectin
and TGF-b. Further research is necessary to identify the
causal relationship between TG2 and AAA rupture.
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